Muscular Dystrophy Canada
Toronto, ON M4P 2E5
CEO: Barbara Stead-Coyle
Board Chair: Buzz Green
Charitable Reg. #: 10775 5837 RR0001
Grade: BThe grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Full-time staff #55
Avg. Compensation $71,577
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||0|
|$160k - $200k||1|
|$120k - $160k||5|
|$80k - $120k||4|
|$40k - $80k||0|
About Muscular Dystrophy Canada:
Founded in 1954, Muscular Dystrophy Canada (MDC) works to improve the lives of the over 50,000 Canadians affected by neuromuscular disorders. These disorders are characterized by progressive muscle weakening and dysfunction. Current treatments focus on managing symptoms – there is no known cure. MDC offers services to people and families affected by neuromuscular disorders and funds research looking for a cure. MDC’s key program buckets are research, services, and education and information.
Muscular Dystrophy Canada spent $1.3m on Services programs in F2016, making up 42% of annual program costs. Through the Financial Assistance program, MDC reports spending $1.1m to help 497 Canadians purchase 659 medically-prescribed assistive devices in 2016. MDC also reports granting 220 requests for financial assistance through its Community Services Fund during the year.
The charity’s Information and Education program, designed to raise awareness and spread knowledge about neuromuscular disorders, accounted for 33% of program costs in F2016. Muscular Dystrophy Canada reports reaching over 1,934 people through 79 awareness presentations and distributing 3,231 information packages in 2016. The charity also ran 16 Educational Forums that 515 people attended.
Research accounted for 17% of program costs in F2016 – Muscular Dystrophy Canada disbursed $533k over the year. This included $191k in Respiratory Care ‘seed grants’ that funded 4 new respiratory research projects. In its most recent 2016 Research in the Works report, MDC lists 24 current grant projects that it is funding or helps fund. Muscular Dystrophy Canada described a breakthrough finding in its 2016 Research report, made by Ottawa Hospital researchers. In November 2015, the lab discovered that Duchenne muscular dystrophy is due to defective stem cell function, as opposed to strictly muscle-fiber dysfunction. The findings were published in Nature Medicine that same month. Researchers believe that this new information could lead to more effective treatments. Researchers at SickKids also made a breakthrough in 2016 when they successfully used CRISPR, an innovative gene-editing technique, to remove a duplicate gene from a cell affected by Duchenne muscular dystrophy. The experiment removed the disease-causing mutation and restored the gene’s normal function.
Muscular Dystrophy Canada is a big-cap charity with donations and special events fundraising of $9.2m in F2016. Administrative costs are 24% of revenues and fundraising costs are 46% of donations. Per dollar donated to the charity, $0.31 goes to its programs, which falls outside Ci’s reasonable range for overhead spending. The charity’s funding reserves of $10.8m can cover annual program costs for 3.4 years.
This report is an update that is currently being reviewed by Muscular Dystrophy Canada. Comments and edits may be forthcoming.
Updated on May 29, 2017 by Katie Khodawandi.
Financial RatiosFiscal year ending March
|Administrative costs as % of revenues||23.7%||21.2%||19.6%|
|Fundraising costs as % of donations||45.5%||42.8%||39.1%|
|Program cost coverage (%)||343.1%||303.4%||301.3%|
Summary Financial StatementsAll figures in $000s
|Cash flow from operations||(123)||632||1,510|